# OnCo record paper-nct03706365-lancet-oncol-2025 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-nct03706365-lancet-oncol-2025/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-nct03706365-lancet-oncol-2025" ;
  schema:name "Abemaciclib plus abiraterone in patients with metastatic castration-resistant prostate cancer (CYCLONE 2): a randomised, double-blind, placebo-controlled, phase 3 trial"@en ;
  schema:description "Published report from the CYCLONE 2 trial registered as NCT03706365, in The Lancet Oncology (2025), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-nct03706365-lancet-oncol-2025/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s1470-2045(25)00475-9>, <https://pubmed.ncbi.nlm.nih.gov/41167216/>, <https://europepmc.org/article/MED/41167216>, <https://clinicaltrials.gov/study/NCT03706365> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s1470-2045(25)00475-9> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Smith M, Piulats J, Todenhöfer T, et al." ;
  onco:trials <https://onco.cc/trials/nct03706365/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .